Welcome to Markets Desk, your midday read on what's moving money and markets.
Bank of America is raising a red flag on equities, pointing to two converging warning signs — a surge in bond market anxiety and a pullback in financial stocks. Historically, that combination has preceded sharper corrections, and BofA's strategists aren't dismissing it as noise. Traders would be wise to pay attention.
Shifting to the consumer space, Peter Rahal — the entrepreneur who built RxBar and sold it to Kellogg's — has officially crossed the billionaire threshold with his second venture. His company Medici Brands, home to David protein bars and better-for-you candy brand HallPass, just raised two hundred fifty million dollars at a two point two five billion dollar valuation. That's a serious vote of confidence from investors in the premium nutrition category.
And in biotech, Fate Therapeutics received a fifteen million dollar grant from the California Institute for Regenerative Medicine to advance its cell therapy program targeting lupus nephritis. The funding supports clinical development of FT eight nineteen, an iPSC-derived treatment, and adds non-dilutive capital to a company navigating a demanding development pipeline.
That's the tape. Markets Desk, signing off the floor.
